16 ADHD Clinical Trials in Baltimore, MD (2026)

Q: How do I join a clinical trial in Baltimore?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you.

Recruiting ADHD Studies in Baltimore

NCT03193970Recruiting

Measuring Surgical Recovery After Radical Cystectomy

The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of th...

Baltimore, MD2,000 participantsM.D. Anderson Cancer Center

View Study Details

NCT07097545Recruiting

Change in Social Media Use and Well-being Among College Students Receiving a Two-week Exercise or Mindfulness Intervention

The investigators will be randomizing 300 college student participants with high levels of social media use into either a 1) control condition (no intervention), a 2) mindfulness meditation cognitive ...

Baltimore, MDNA300 participantsJohns Hopkins Bloomberg School of Public Health

View Study Details

NCT04421248Recruiting

Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder (ADHD) is the most commonly diagnosed neurobehavioral disorder in childhood. Children with ADHD struggle in school due to problems with attention and high leve...

Baltimore, MDPHASE4214 participantsDonald Gilbert, MD, MS, FAAN, FAAP

View Study Details

NCT06525571Recruiting

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

Comparing white-light cystoscopy (WLC) and blue-light cystoscopy (BLC) in TURBT for high risk (HR) non-muscle invasive bladder cancer (NMIBC) patients is crucial to determine the most effective method...

Baltimore, MDPHASE3200 participantsJohns Hopkins University

View Study Details

NCT06810180Recruiting

Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD

Attention deficit/hyperactivity disorder (ADHD) can present differently in individuals, with some individuals having difficulty with attentional control, hyperactivity, impulsivity, emotion dysregulat...

Baltimore, MDNA200 participantsHugo W. Moser Research Institute at Kennedy Krieger, Inc.

View Study Details

NCT05973838Recruiting

Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention

The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce po...

Baltimore, MDNA160 participantsUniversity of Maryland, College Park

View Study Details

NCT07225205Recruiting

Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy

Radical cystectomy is the standard of care for muscle invasive bladder cancer, however despite advances, it is still associated with high morbidity. Many complications may be driven by dehydration and...

Baltimore, MDNA130 participantsJohns Hopkins University

View Study Details

NCT06929286Recruiting

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

The purpose of this study is to compare the effectiveness of different FDA-approved/NCCN-recommended drug treatments for NMIBC. In particular, the FDA-approved drug nadofaragene firadenovec will be co...

Baltimore, MDPHASE3125 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06015893Recruiting

Semaglutide Therapy for Alcohol Reduction (STAR)

Background: Alcohol use disorder (AUD) is a problematic pattern of alcohol use accompanied by clinically significant medical consequences. Medications can help most people reduce their drinking, but ...

Baltimore, MDPHASE280 participantsNational Institute on Drug Abuse (NIDA)

View Study Details

NCT05649306Recruiting

Gender Related Coping and Survivorship for Genitourinary Cancers

This research is being done to learn more about coping and survivorship of women with bladder cancer, specifically regarding psychosocial distress and sexual dysfunction. This study is a non-therapeut...

Baltimore, MD80 participantsJohns Hopkins University

View Study Details

NCT05792722Recruiting

Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy

The purpose of this clinical trial is to determine if prostate-capsule-sparing cystectomy improves functional outcomes without comprising oncologic outcomes in male patients receiving a radical cystec...

Baltimore, MDNA70 participantsJohns Hopkins University

View Study Details

NCT05312671Recruiting

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

This is a single arm, Phase II trial involving the use of atezolizumab plus platinum and etoposide for patients with locally advanced urothelial cancer. The primary goal of this trial is to assess the...

Baltimore, MDPHASE263 participantsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

View Study Details

NCT04789044Recruiting

Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)

The overall objective of this study is to determine the safety of PEG fusion when used with primary repair or reconstruction in patients with an acute upper extremity peripheral nerve injury. PEG is s...

Baltimore, MDPHASE240 participantsMajor Extremity Trauma Research Consortium

View Study Details

NCT06637423Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

The goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose that people can take without having cert...

Baltimore, MDPHASE132 participantsMerck Sharp & Dohme LLC

View Study Details

NCT04781972Recruiting

Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD

The investigators' goal is to develop neuroimaging biomarkers to predict response to treatment with methylphenidate, which then can be used in the development of novel pharmacological treatments for a...

Baltimore, MDPHASE430 participantsJohns Hopkins University

View Study Details

NCT07594652Recruiting

Medication Treatment of ADHD in Pediatric Epilepsy

This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy....

Baltimore, MDPHASE425 participantsHugo W. Moser Research Institute at Kennedy Krieger, Inc.

View Study Details

About ADHD Clinical Trials in Baltimore

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.

There are currently 16 adhd clinical trials recruiting participants in Baltimore, MD. These studies are seeking a combined 3,749 participants. Research is being sponsored by M.D. Anderson Cancer Center, Johns Hopkins Bloomberg School of Public Health, Donald Gilbert, MD, MS, FAAN, FAAP and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ADHD Clinical Trials in Baltimore — FAQ

Are there adhd clinical trials in Baltimore?

Yes, there are 16 adhd clinical trials currently recruiting in Baltimore, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Baltimore?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.

Are clinical trials in Baltimore free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.

What adhd treatments are being tested?

The 16 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.

Data updated July 20, 2026 from ClinicalTrials.gov